Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2
Monday, July 20, 2020Pfizer Inc and BioNTech SE announced an agreement with the United Kingdom to supply million doses of their BNT mRNAbased vaccine candidate against SARSCoV currently in development subject to clinical success and regulatory approval Financial details...
GSK and CureVac announce strategic mRNA technology collaboration
Monday, July 20, 2020GlaxoSmithKline plc and CureVac today announced the signing of a strategic collaboration agreement for the research development manufacturing and commercialisation of up to five mRNAbased vaccines and monoclonal antibodies mAbs targeting infectious d...
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in Ovarian Cancer in China
Saturday, July 18, 2020BeiGene Ltd a commercialstage biotechnology company focused on developing and commercializing innovative molecularlytargeted and immunooncology drugs for the treatment of cancer announced that the Center for Drug Evaluation CDE of the China National...
Celltrion Launches Human Clinical Trial of Potential COVID-19 Antiviral Antibody Treatment Following Positive Pre-Clinical Results
Saturday, July 18, 2020Celltrion Group announced the launch of its Phase I human clinical trial investigating a potential antiviral antibody treatment for patients with COVID The inhuman study follows positive preclinical results for the treatment candidate and subsequent...
Humanigen Expands Partnership with Catalent Biologics to Manufacture Investigational COVID-19 Therapeutic Candidate Lenzilumab
Friday, July 17, 2020Catalent and Humanigen Incannounced the expansion of their relationship under which Catalent will provide development manufacturing and commercialization services for lenzilumab Humanigens proprietary Humaneered antihuman granulocyte macrophagecolony...
Oncorus Announces Clinical Trial Collaboration with Merck to Evaluate the Combination of Oncorus’ ONCR-177 with Merck’s KEYTRUDA®
Friday, July 17, 2020Oncorus Announces Clinical Trial Collaboration with Merck to Evaluate the Combination of Oncorus ONCR with Mercks KEYTRUDA pembrolizumab in Adult Patients with Advanced andor Refractory Cutaneous Subcutaneous or Metastatic Nodal Solid Tumors
Novocure Announces Clinical Trial Collaboration with MSD to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Non-Small Cell Lung Cancer
Thursday, July 16, 2020Novocure announced it has entered into a clinical trial collaboration agreement with MSD a tradename of Merck Co Inc through a subsidiary to develop Tumor Treating Fields together with MSDs antiPD therapy KEYTRUDA pembrolizumab for treatment of nons...
Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology from GSK
Thursday, July 16, 2020Orchard Therapeutics a global gene therapy leader today announced that the company has entered into two worldwide royaltybearing license agreements with GlaxoSmithKline plc GSK LSENYSE GSK for use of their proprietary lentiviral stable cell line tech...
Sanofi and MD Anderson announce strategic collaboration to accelerate oncology research and development
Wednesday, July 15, 2020Sanofi and The University of Texas MD Anderson Cancer Center today announced a fiveyear strategic collaboration to accelerate the development of investigational treatments including targeted and immunetherapies for patients with cancer The alliance w...
Fate Therapeutics Announces Exclusive License Agreement with Baylor College of Medicine for Rejection-resistant iPSC-derived Cellular Therapies
Wednesday, July 15, 2020Fate Therapeutics Inc a clinicalstage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders today announced that the Company entered into an exclusive license agreement with Bayl...
